| Issue Date | Title | Author(s) |
| 2023 | A Microfluidic Approach for Enrichment and Single-Cell Characterization of Circulating Tumor Cells from Peripheral Blood. | Radfar, P; Ding, L; Es, HA; Warkiani, ME |
| 2023-01-01 | Circulating Tumour Cell Isolation and Molecular Profiling; Potential Therapeutic Intervention | Radfar, P; Es, HA; Kulasinghe, A; Thiery, JP; Warkiani, ME |
| 2022-09-12 | Conjugated Linoleic Acid Treatment Attenuates Cancerous features in Hepatocellular Carcinoma Cells | Miri-Lavasani, Z; Torabi, S; Solhi, R; Shokouhian, B; Afsharian, P; Heydari, Z; Piryaei, A; Farzaneh, Z; Hossein-khannazer, N; Es, HA; Zahmatkesh, E; Nussler, A; Hassan, M; Najimi, M; Vosough, M; Faroni, A |
| 2022-12-15 | DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine. | Fatemi, N; Tierling, S; Es, HA; Varkiani, M; Mojarad, EN; Aghdaei, HA; Walter, J; Totonchi, M |
| 2023-09 | (‐)‐Epigallocatechin‐3‐gallate induced apoptosis by dissociation of c‐FLIP/Ku70 complex in gastric cancer cells | Felordi, MS; Alikhani, M; Farzaneh, Z; Choshali, MA; Ebrahimi, M; Es, HA; Piryaei, A; Najimi, M; Vosough, M |
| 2021-07-23 | Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP). | Es, HA; Mahdizadeh, H; Asl, AAH; Totonchi, M |
| 2022-08-29 | Hepatogenesis and hepatocarcinogenesis: Alignment of the main signaling pathways | Shokouhian, B; Es, HA; Negahdari, B; Tamimi, A; Shahdoust, M; Shpichka, A; Timashev, P; Hassan, M; Vosough, M |
| 2022-12-07 | HNF4α is possibly the missing link between epithelial–mesenchymal transition and Warburg effect during hepatocarcinogenesis | Shokouhian, B; Negahdari, B; Heydari, Z; Totonchi, M; Es, HA; Piryaei, A; Mostafavi, E; Vosough, M |
| 2021-07 | Machine learning reveals mesenchymal breast carcinoma cell adaptation in response to matrix stiffness. | Rozova, VS; Anwer, AG; Guller, AE; Es, HA; Khabir, Z; Sokolova, AI; Gavrilov, MU; Goldys, EM; Warkiani, ME; Thiery, JP; Zvyagin, AV |
| 2023-01 | Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma. | Pourhamzeh, M; Asadian, S; Mirzaei, H; Minaei, A; Shahriari, E; Shpichka, A; Es, HA; Timashev, P; Hassan, M; Vosough, M |
| 2021-04 | Novel molecular targets in gastric adenocarcinoma. | Ramezankhani, R; Solhi, R; Es, HA; Vosough, M; Hassan, M |
| 2021-10-13 | Pirfenidone Reduces Epithelial–Mesenchymal Transition and Spheroid Formation in Breast Carcinoma through Targeting Cancer-Associated Fibroblasts (CAFs) | Es, HA; Cox, TR; Sarafraz-Yazdi, E; Thiery, JP; Warkiani, ME |
| 2023-09 | SC3_3. FKBPL signalling in placental development and preeclampsia | Ghorbanpour, S; Richards, C; Pienaar, D; Sesperez, K; Es, HA; Nikolic, V; Karadzov-Orlic, N; Mikovic, Z; Stefanovic, M; Cakic, Z; Alqudah, A; Cole, L; Gorrie, C; Mcgrath, K; Kavurma, M; Warkiani, M; McClements, L |
| 2020-10 | β-radiating radionuclides in cancer treatment, novel insight into promising approach. | Asadian, S; Mirzaei, H; Kalantari, BA; Davarpanah, MR; Mohamadi, M; Shpichka, A; Nasehi, L; Es, HA; Timashev, P; Najimi, M; Gheibi, N; Hassan, M; Vosough, M |
